Advertisements

Famotidine Tablet

Quick links to important sections

Famotidine Tablet

Advertisements
Advertisements

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Famotidine Tablet

Quick Facts

Property Description
Active ingredient Famotidine
Form Oral tablet (e.g., film-coated or chewable)
Pharmacological class Histamine H2-receptor antagonist (H2 blocker)
Common use Reduction of stomach acid and related discomfort
Origin Synthetic compound

What Type of Medicine is Famotidine Tablet?

Famotidine Tablet is a pharmaceutical preparation containing the active ingredient Famotidine, a substance classified as a Histamine H2-receptor antagonist or H2 blocker. This medication is a synthetic compound, manufactured as a single-ingredient product for oral use. Famotidine belongs to the class of medications that decrease the amount of acid made in the stomach.

As an H2 blocker, Famotidine acts by engaging in competitive inhibition, interrupting the signal that promotes acid secretion. It blocks the action of the chemical messenger histamine at the specific H2 receptors found on the parietal cells of the stomach lining. This precise mechanism differentiates it from antacids and establishes its role as an antisecretory agent.


Famotidine Tablet's High-Level Purpose and Form

The high-level purpose of the Famotidine Tablet is its antisecretory action, which involves reducing the volume and concentration of acid secreted into the stomach. It functions as a gastric acid secretion inhibitor. This function is typically employed in scenarios where patients experience discomfort due to excess stomach acid. The medication is delivered as an oral tablet, intended to be swallowed, and is available as a film-coated tablet or as a chewable tablet variation.

This antisecretory agent modifies the internal chemical environment of the upper gastrointestinal tract. The tablet comprises the active ingredient Famotidine along with various pharmaceutical excipients. These inactive components are used to ensure the tablet's structural integrity and stability, facilitating the delivery of the active substance to the systemic circulation for its intended acid-reducing effect.

Regulatory References

  1. MedlinePlus
Advertisements

What side effects are possible with Famotidine Tablet?

Possible Side Effects and Safety Information

The safety profile of Famotidine Tablet is classified by regulatory authorities based on the frequency and the System-Organ Class (SOC) affected. The most frequently documented adverse reactions, classified as Common, include headache and dizziness. Effects classified as Uncommon involve various Gastrointestinal disorders, such as nausea, vomiting, abdominal pain, and flatulence, along with general symptoms like fatigue and rash.

Officially Documented Safety Considerations

Classification Examples of Adverse Reactions
Rare Hypersensitivity reactions (e.g., urticaria, angioedema), somnolence, paresthesia.
Very Rare Severe cutaneous reactions (e.g., Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis), Arrhythmias, Confusion, Hepatitis, Blood Dyscrasias (e.g., Agranulocytosis).

Serious adverse reactions, though rare, are explicitly documented in regulatory sources and involve the Cardiovascular, Hepatobiliary, Immune, and Blood and Lymphatic System Disorders. These documented serious reactions include QT prolongation, severe cutaneous reactions, and blood count abnormalities.

Population-Specific Safety Notes

The official labeling notes specific safety considerations for certain patient populations. Older adults may have an increased risk for Central Nervous System (CNS) adverse reactions, including confusion and hallucinations. Patients with renal impairment (kidney issues) also face an elevated risk of CNS adverse reactions and QT prolongation due to reduced drug clearance. A final regulatory restriction notes that symptomatic relief from Famotidine therapy does not rule out the presence of gastric malignancy, and evaluation for this condition is advised prior to treatment.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation describes the manifestations of Famotidine Tablet overdose as being generally similar to the adverse reactions experienced during normal use, though potentially more severe. The primary systems affected are the Central Nervous System (CNS) and the cardiovascular system. Documented CNS manifestations include confusion, delirium, hallucinations, agitation, and lethargy. More severe outcomes noted in prescribing information include the potential for convulsions and specific cardiovascular changes like QT prolongation.

Immediate medical help must be sought following any known or suspected overdose. Government guidance mandates that individuals seek immediate medical attention and contact a Poison Control Center right away. Emergency services should be called immediately if the affected person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.

Patients with moderate or severe renal impairment and elderly patients are identified in official labeling as groups susceptible to increased CNS adverse effects during overdose due to reduced drug clearance. Treatment is officially defined as symptomatic and supportive, requiring clinical monitoring and measures to remove unabsorbed material from the gastrointestinal tract.

Advertisements

Therapeutic Uses of Famotidine Tablet

Main Uses of Famotidine

Famotidine belongs to a class of medications known as histamine-2 (H2) blockers. It is primarily used to manage conditions caused by excessive acid production in the stomach. By reducing the amount of acid secreted by the stomach lining, it helps alleviate discomfort and allows the digestive tract to heal.

Gastroesophageal Reflux Disease (GERD)

Famotidine is frequently used to treat gastroesophageal reflux disease, a condition where stomach acid flows back into the esophagus. This backward flow can cause irritation and inflammation of the esophageal lining. The medication helps relieve the common symptoms associated with this reflux, such as heartburn and an acid taste in the back of the mouth.

Peptic Ulcer Disease

The medication is indicated for the treatment and prevention of ulcers in the stomach and the duodenum (the first part of the small intestine). By lowering acid levels, famotidine creates an environment that promotes the healing of existing sores and helps prevent new ulcers from forming, especially in patients prone to recurrent ulceration.

Pathological Hypersecretory Conditions

Famotidine is used to manage rare medical conditions characterized by the chronic overproduction of stomach acid, such as Zollinger-Ellison syndrome. In these cases, the medication helps control the high levels of acid that would otherwise lead to severe complications in the digestive system.

Benefits and Outcomes

Symptom Relief

The primary benefit of famotidine is the reduction of painful symptoms associated with acid-related disorders. This includes the management of persistent heartburn and indigestion, which can significantly impact daily comfort.

Protection of the Esophagus

For individuals with chronic reflux, famotidine helps protect the esophagus from the erosive effects of stomach acid. This can prevent long-term damage and complications such as esophagitis (inflammation of the esophagus).

Support for Digestive Healing

By maintaining a less acidic environment, famotidine facilitates the natural healing process of the gastric and intestinal mucosa. This is essential for the recovery of patients with active ulcers or those recovering from erosive digestive issues.

Regulatory References

  1. NIH MedlinePlus guidance
Advertisements

Eligibility and Restrictions for Use

Famotidine tablets are generally used to treat and prevent ulcers in the stomach and intestines, as well as conditions like gastroesophageal reflux disease (GERD), which cause excessive stomach acid.

Who Can Use Famotidine?

  • Adults and Children (Prescription Use): Famotidine is approved for use in adults and in certain pediatric patients, particularly those weighing 40 kg or more, for conditions such as active ulcers, GERD, and erosive esophagitis. Lower strength, over-the-counter (OTC) famotidine may be used in children 12 years and older for heartburn relief.
  • Older Adults (Geriatric Patients): Use in older adults is possible but often requires a reduced dosage due to an increased risk of side effects, especially if there is reduced kidney function.
  • Pregnant or Breastfeeding Individuals: Use during pregnancy or while breastfeeding requires consultation with a healthcare provider to weigh the potential benefits against any risks to the infant.

Who Should Exercise Caution or Avoid Famotidine?

  • Allergy or Hypersensitivity: Patients who have had a serious allergic reaction (hypersensitivity) to famotidine or other H2 receptor antagonists (H2 blockers) should not use this medication.
  • Kidney Problems: Individuals with moderate to severe kidney impairment require a dosage adjustment and close monitoring by a doctor, as famotidine is cleared by the kidneys, and impairment can lead to drug accumulation and increased side effects.
  • Certain Symptoms: Do not use OTC famotidine if you experience alarming symptoms such as bloody or black stools, vomiting blood, or trouble swallowing. These symptoms require immediate medical attention.
  • Drug Interactions: Famotidine can interact with other medications, potentially reducing their absorption or increasing their effects. A healthcare provider should review all current medications before treatment begins.
Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Famotidine's official interaction profile is primarily governed by its acid-reducing effect, which can significantly alter the absorption of certain co-administered drugs. This pharmacokinetic effect, classified as pH-Dependent Absorption, requires administration restrictions for several substance categories.

Documented Interaction Patterns

  • Reduced Systemic Exposure: Co-administration with Famotidine may decrease the plasma concentrations of certain Tyrosine Kinase Inhibitors (e.g., Erlotinib, Dasatinib), Antifungal Agents (e.g., Ketoconazole, Itraconazole), and certain Antivirals (e.g., Atazanavir), potentially reducing their effectiveness. Official labeling advises avoiding these combinations or mandates strict time separation.
  • Altered Clearance/Increased Exposure: Famotidine's renal elimination pathways lead to interactions that increase plasma levels of some co-administered drugs. Specifically, Tizanidine concentrations may increase due to enzyme-mediated effects, and Erdafitinib concentrations may increase due to altered renal clearance. Concomitant use with both Probenecid and Tizanidine is advised to be avoided.

Mandatory Separation Rules

Administration of certain substances must be separated by time to mitigate interactions:

Interacting Substance Mandatory Separation Rule
Antacids Must be administered 1 to 2 hours after Famotidine.
Sucralfate Must be avoided within two hours of a Famotidine dose.
Erlotinib / Ketoconazole Must be taken 2 hours before or 10 hours after Famotidine (varies by agent).

Population Considerations

Patients with moderate to severe renal impairment are at an increased risk of adverse reactions due to slower drug elimination, necessitating official dosage adjustment.

Advertisements

Mechanism of Action

Blocking the Histamine H2 Receptor

Famotidine functions as a highly selective competitive H2 receptor antagonist. Its mechanism involves directly targeting and binding to the histamine H2 receptors located on the basolateral membrane of the parietal cells in the gastric mucosa. By occupying the receptor site, the drug prevents the binding of the natural mediator, histamine, thereby interrupting the primary signal for acid secretion.

Modulating the Acid Secretion Cascade

This receptor blockade interrupts the intracellular signal transduction pathway that normally follows histamine binding. The drug limits the subsequent activation, insertion, and overall activity of the proton pumps ( H^+/ K^+ ATPase), which are the final effectors responsible for transporting HCl into the stomach lumen. This early molecular modulation contributes to the functional adjustment of the acid-secreting machinery.

Physiological Consequence

The ultimate consequence of these targeted mechanistic actions is a sustained reduction in gastric acid output. The resulting decrease in the volume and acidity of gastric secretions modulates the physiochemical conditions within the stomach.

Advertisements

Dosage and Administration Information

Instruction Map: How to use Famotidine Tablet — Administration Guidelines

The use of Famotidine tablets is guided by standardized protocols which stipulate the route, dosage ranges, and specific administration conditions for the medicine.


Administration Scope

Feature Administration Guideline
Route of administration Oral administration only.
Dosing schedule Regimens typically prescribe 20 mg or 40 mg doses. For active conditions, usage may be 40 mg once daily at bedtime or 20 mg twice daily. Maximum doses for pathological hypersecretory conditions can reach up to 160 mg every six hours.
Timing in relation to meals (if applicable) The tablet may be taken with or without food.
Preparation requirements (if applicable) Film-coated tablets must be swallowed whole. Chewable tablets are required to be chewed thoroughly before swallowing.
Age-group administration rules No specific adjustment is mandated for older adults based on age alone. However, dose adjustments are required for patients with severe renal impairment to account for reduced drug clearance.
Missed-dose rules If a dose is missed, it should be taken as soon as recalled. If the time is near the next scheduled dose, the missed dose is skipped, and the regular schedule is maintained; double doses are not to be taken.
Special procedural conditions For patients with moderate to severe renal impairment (e.g., creatinine clearance < 60 mL/min), the maximum dose should be reduced or the dosing interval extended to between 36 and 48 hours.

Instruction Classifications (High-Level)

Classification Description
Administration method type Oral ingestion.
Frequency pattern Daily (once daily) to multiple times per day (twice daily or every six hours), as dictated by the specific regimen.
Use-context constraints Dosage adjustments are tied to documented physiological metrics (severe renal impairment).

Resulting Procedural Structure

Official step sequence:

  • The tablet must be taken orally, either swallowed whole or chewed based on the formulation type.
  • The daily schedule follows a once- or twice-daily pattern, often including administration at bedtime.
  • Dosing duration is defined as short-term (e.g., up to 8 or 12 weeks) or long-term (e.g., 1 year maintenance).

Connection to the overall use protocol: This procedural framework establishes the standardized method of consumption and the required schedule for Famotidine Tablet, adhering to established guidelines for safety and administration. It formalizes the precise dose ranges and clarifies the limited circumstances—such as renal function decline—under which the dosing regimen must be modified. This protocol ensures adherence to the approved method of use.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence

Famotidine is a histamine H2-receptor antagonist widely studied for its role in reducing stomach acid production. Recent clinical evidence continues to support its use for short-term treatment of active duodenal ulcers, active benign gastric ulcers, and the management of gastroesophageal reflux disease (GERD).

Efficacy and Indications

Studies have evaluated famotidine’s effect across various acid-related disorders. In trials for duodenal ulcers, the drug was investigated for its ability to promote healing. Similarly, research has examined its utility in gastric ulcer treatment, often comparing different dosing regimens.

  • GERD Management: Research indicates that famotidine may be used for the symptomatic relief of GERD. Trials have explored its effectiveness in preventing erosive esophagitis from recurring.
  • Hypersecretory Conditions: The drug is also investigated for long-term use in conditions characterized by excessive acid secretion, such as Zollinger-Ellison syndrome. Studies focus on maintaining adequate acid suppression with the lowest possible effective dose.

Safety Profile and Monitoring

Famotidine is generally considered to be well-tolerated. Clinical data indicates that the most commonly reported adverse effects are mild and transient, potentially including headache and dizziness. Serious adverse events are rare.

Research has explored the need for dose adjustments in populations with compromised kidney function, as famotidine is primarily eliminated by the kidneys. Healthcare providers may need to monitor patients with impaired renal function closely to minimize the risk of drug accumulation.

Key Studies & References

  1. Famotidine - StatPearls - NCBI Bookshelf
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Famotidine Tablet (FAQ)


Q: Does Famotidine Tablet help with indigestion?

Official prescribing information indicates that Famotidine has been used for the relief of symptoms related to indigestion, which involves discomfort or pain in the upper abdomen. As an antisecretory agent, its primary role is to reduce the amount of acid produced in the stomach.


Q: What are the main differences between Famotidine and antacids?

Famotidine is an H2 blocker, meaning it works by blocking the signals that cause the stomach to produce acid. Antacids, in contrast, are a class of medicine that functions by chemically neutralizing the acid that is already present in the stomach. This difference in mechanism means they act differently in the body.


Q: Can Famotidine Tablet cause stomach issues like diarrhea or constipation?

Official regulatory safety information notes that gastrointestinal disorders are listed as potential side effects, including abdominal pain and nausea. Some regulatory lists include reports of constipation or diarrhea, which are typically categorized among the uncommon effects.


Q: Is it safe to take Famotidine Tablet every day?

The administration protocols defined in official prescribing information include regimens that involve administration once or twice daily. The approved duration of use varies widely, ranging from short-term treatment for active conditions to extended maintenance regimens.


Q: Is there evidence that Famotidine Tablet can help with acid reflux symptoms at night?

Official dosing schedules for certain acid-related conditions include administration once daily at bedtime. This administration time is intended to provide a sustained effect that covers the overnight hours.


Q: Does the medicine come in different strengths, and what are they used for?

Famotidine is manufactured in various strengths, as documented in official drug product listings. Lower doses are typically intended for over-the-counter (OTC) relief of occasional heartburn, while higher doses are reserved for the prescription treatment of severe conditions like ulcers and GERD.


Q: What is the difference between prescription and over-the-counter Famotidine Tablet?

The main difference lies in the approved strength and the conditions they are intended to treat. Prescription strengths are used for managing conditions like active ulcers and severe GERD. Lower, over-the-counter (OTC) strengths are intended for the prevention and relief of occasional, non-severe heartburn.


Q: What does 'use conditions' mean in the context of Famotidine Tablet?

In regulatory documentation, the term 'use conditions' refers to specific patient characteristics or physiological statuses that are referenced in determining appropriate use of the medicine. For example, severe kidney impairment is a use condition that requires official adjustments to the standard dosage or frequency.


Q: Does Famotidine Tablet treat the cause of acid reflux or just the symptoms?

Famotidine is classified as an antisecretory agent because its primary function is to block the production of stomach acid. This action addresses the acid levels that lead to symptoms, meaning it is used for the management of the symptoms of acid-related conditions.


Q: Why is it important to know about all the ingredients in Famotidine Tablet?

Official labeling includes a complete list of all ingredients, including the active ingredient and inactive components known as excipients. This information is provided to ensure patients can confirm the absence of any substance to which they may have a known allergy or hypersensitivity, which is relevant information for anyone with a known allergy.


Q: Is Famotidine Tablet the same type of medicine as Pepcid?

Famotidine is the globally recognized name for the active ingredient in this medicine. Its original brand-name designation is Pepcid. Both the generic Famotidine and Pepcid belong to the same class of medicine, known as H2 blockers.


Q: How quickly does Famotidine Tablet start working after you take it?

According to the medicine's official clinical pharmacology information, the amount of Famotidine in the body typically reaches its highest concentration within one to three hours after oral administration. This time frame often corresponds to the onset of the medicine's full action.


Q: Is it possible for Famotidine Tablet to interact with commonly used over-the-counter pain relievers?

Official regulatory summaries of drug interactions do not typically list major pharmacokinetic interactions between Famotidine and commonly used over-the-counter pain relievers. Official guidance emphasizes the importance of reviewing all medicines and products with a healthcare provider to check for potential effects.


Q: How long do the effects of Famotidine Tablet typically last?

Official clinical data concerning the suppression of gastric acid production suggests that the effect of a single dose of Famotidine may last up to 10 to 12 hours. This duration helps inform the appropriate dosing schedule.


Q: What should I know about taking Famotidine Tablet if I have a liver condition?

Official prescribing information notes that Famotidine is primarily cleared from the body by the kidneys, not the liver. Due to this, no specific dose adjustment is currently required for patients with documented hepatic (liver) impairment.


Q: Does taking Famotidine Tablet cause vitamin deficiencies?

Regulatory safety information for this class of medicine notes that long-term use may potentially be associated with the development of a Vitamin B12 deficiency. This warning is primarily observed in individuals undergoing long-term treatment.


Q: Are there any food or drinks that can interact with Famotidine Tablet?

The medicine may be taken with or without food according to official administration instructions. The official drug interaction summaries typically do not list specific foods or drinks as having known major pharmacokinetic interactions that would significantly alter how the medicine works.


Q: Has Famotidine Tablet been studied in relation to H. pylori infections?

Yes, clinical research has examined Famotidine for its role as a component of combination therapy used for the eradication of Helicobacter pylori bacteria. This is typically done as part of a multi-drug regimen.


Q: Is it safe to take Famotidine Tablet with blood thinners?

The official drug interaction profile for Famotidine does not list major pharmacokinetic interactions with the most common anticoagulant (blood thinner) medications. Regulatory guidance requires reviewing all co-administered medicines with a healthcare provider to account for any specific concerns.


Q: Is the effect of Famotidine Tablet reduced by smoking?

Some regulatory documents indicate that smoking may potentially reduce the effectiveness of Famotidine Tablet in treating acid-related conditions. This potential interaction is a consideration noted in official guidance.


Q: Does taking Famotidine Tablet affect blood pressure?

Official safety information for Famotidine Tablet does not typically list generalized changes in blood pressure, such as hypotension (low blood pressure) or hypertension (high blood pressure), among the common or uncommon adverse reactions. Rare adverse events involving the cardiovascular system are noted.


Q: Why is official regulatory information important for understanding Famotidine Tablet?

Regulatory information is the authoritative, verifiable record of the medicine's approved uses and safety profile, established by government drug agencies. This information is essential because it details the scientifically documented risks, required administration procedures, and official safety warnings based on rigorous review.


Q: What is the chemical name for Famotidine?

The full chemical name for the active ingredient, Famotidine, is N' -sulfamoyl-3-[((2-((diaminomethylene)amino)thiazol-4-yl)methyl)thio]propanimidamide. This formal chemical name is recorded in the official product description documents.


Q: Can Famotidine Tablet be taken with supplements or vitamins?

Famotidine is known to potentially affect the absorption of certain vitamins, such as Vitamin B12, especially during long-term administration. While official drug interaction lists focus primarily on regulated medicines, it is recommended to review the use of all supplements and vitamins with a healthcare provider.


Q: Is it listed as a medicine that interacts with grapefruit juice?

Official regulatory summaries of drug interactions do not typically include grapefruit juice as a substance known to have a significant effect on the way Famotidine Tablet is processed by the body. Therefore, no specific warning about this interaction is usually noted.


Q: Does Famotidine Tablet have any known interactions with alcohol?

While official labeling typically does not cite major pharmacokinetic interactions with alcohol, some regulatory information advises caution regarding alcohol consumption during use. This is generally recommended as a measure of prudence.

Advertisements

How should Famotidine Tablet be stored and disposed of?

Famotidine tablets must be stored at Controlled Room Temperature, which is defined as 20 C to 25 C (68 F to 77 F), with brief temperature excursions allowed between 15 C and 30 C. To maintain product stability, the tablets must be protected from moisture and should remain in the tightly closed container they were dispensed in. The medication must also be stored out of the reach and sight of children. For disposal, unused or expired tablets should first be taken to a drug take-back program. If a program is unavailable, the tablets may be discarded in household trash after being removed from the original container, mixed with an undesirable substance like coffee grounds or dirt, and sealed in a bag.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Famotidine Tablet found in:

A-Z Index: